Guidelines outline recommendations for evaluating fetomaternal haemorrhage, emphasizing the need for ongoing evidence review and updates.
The BSH paid the expenses incurred during the writing of this guidance. No additional funding was required for the update of these guidelines. All authors have made a declaration of interests to the B.S.H. which may be viewed on request. The following members of the writing group: L.P., M.H., J.E., K.V., D.H., L.J., S.A.F., C.G. and S.R. have no conflicts of interest to declare. Review process: Members of the writing group will inform the writing group Chair if any new evidence becomes available that would alter the strength of the recommendations made in this document or render it obsolete. The document will be reviewed regularly by the relevant Task Force and the literature search will be re-run every 3 years to search systematically for any new evidence that may have been missed. The document will be archived and removed from the BSH current guidelines website if it becomes obsolete. If new recommendations are made, an addendum will be published on the BSH guidelines website (http://www.b-s-h.org.uk/guidelines). Disclaimer: While the advice and information in this guidance is believed to be true and accurate at the time of going to press, neither the authors, the BSH nor the publishers accept any legal responsibility for the content of this guidance. Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
No takes yet. Share an insight, caveat, or question.
Porter et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: